Browsing by Author Reginster, JY

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 8 of 8
TitleAuthor(s)Issue Date
 
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
Journal:Bone
Sambrook, PNRoux, CDevogelaer, JPSaag, KLau, CSReginster, JYBucci-Rechtweg, CSu, GReid, DM
2012
 
Comparison of a simple clinical risk index and quantitative bone ultrasound for identifying women at increased risk of osteoporosis
Journal:Osteoporosis International
Kung, AWCHo, AYYSedrine, WBReginster, JYRoss, PD
2003
 
Corrigendum to "Bisphosphonates and glucocorticoid osteoporosis in men: Results of a randomized controlled trial comparing zoledronic acid with risedronate" [Bone 50 (2012) 289-295]
Journal:Bone
Sambrook, PNRoux, CDevogelaer, JPSaag, KLau, CSReginster, JYBucciRechtweg, CSu, GReid, DM
2012
 
Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness to quantitative bone ultrasound
Journal:Osteoporosis International
Kung, AWCHo, AYYRoss, PDReginster, JY
2005
 
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis
Journal:Osteoporosis International
Roux, CReid, DMDevogelaer, JPSaag, KLau, CSReginster, JYPapanastasiou, PBucciRechtweg, CSu, GSambrook, PN
2012
 
A simple tool to identify Asian women at increased risk of osteoporosis
Journal:Osteoporosis International
Koh, LKHBen Sedrine, WTorralba, TPKung, AFujiwara, SChan, SPHuang, QRRajatanavin, RTsai, KSPark, HMReginster, JY
2001
 
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (health outcomes and reduced incidence with zoledronic acid once yearly trial): A multicentre, double-blind, double-dummy, randomized controlled trial
Journal:Obstetrical and Gynecological Survey
Reid, DMDevogelaer, JPSaag, KRoux, CLau, CSReginster, JYPapanastasiou, PFerreira, AHartl, FFashola, TMesenbrink, PSambrook, PN
2009
 
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
Journal:The Lancet
Reid, DMDevogelaer, JPSaag, KRoux, CLau, CSReginster, JYPapanastasiou, PFerreira, AHartl, FFashola, TMesenbrink, PSambrook, PN
2009
Showing results 1 to 8 of 8